AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ATROPINE SULPHATE
24 registrations across 5 African markets— 15 active
Markets with ATROPINE SULPHATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Atropine Injection Solution for Injection | 🇿🇲Zambia | Macarthys Laboratories Limited T/A Martindale Pharma | active | Jul 2030 |
| ATROPINE SULPHATE SOLUTION; INJECTION | 🇿🇼Zimbabwe | MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED | active | May 2029 |
| ATROPINE SULPHATE INJECTABLE; INJECTION | 🇿🇼Zimbabwe | CAPS PVT LTD | active | Dec 2027 |
| PHARMA-Q ATROPINE INJECTABLE; INJECTION | 🇿🇼Zimbabwe | PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS | active | Dec 2027 |
| ISOPTO ATROPINE SOLUTION/DROPS; OPHTHALMIC | 🇿🇼Zimbabwe | ALCON PHARM LTD | active | Dec 2027 |
| LOMOTIL | 🇿🇦South Africa | Johnson & Johnson (Pty) Ltd û East London | suspended | Aug 2025 |
| MINIMS ATROPINE SULPHATE 1 % | 🇿🇦South Africa | Soflens (Pty) Ltd | suspended | Sept 2023 |
| CIRATRO_0.5% 0.5%W/V EYE DROPS EYE DROPS | 🇲🇼Malawi | — | expired | Jun 2021 |
| ATROPINE 1MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2018 |
| ATROPINE 0.6MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2012 |
| ATROPINE 0.6MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2006 |
| ATROPINE 0.6MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2005 |
| ATROPINE 1MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2001 |
| ATROPINE 1MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2001 |
| SABAX ATROPINE 1,0 mg/ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ADCO ATROPINE 0,5 mg/ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ATROPINE SULPHATE 0,6 mg/1 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| ATROPINE SULPHATE-FRESENIUS 0,5 mg/1 ml | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| ATROPINE 1 mg UNIMED | 🇿🇦South Africa | Unimed Healthcare (Pty) Ltd | active | Jan 1900 |
| PHARMA-Q ATROPINE INJECTION 0,5 mg/1 ml | 🇿🇦South Africa | Pharma-Q Holdings (Pty) Ltd | active | Jan 1900 |
| ATROPINE 0,6 mg UNIMED | 🇿🇦South Africa | Unimed Healthcare (Pty) Ltd | active | Jan 1900 |
| PHARMA-Q ATROPINE INJECTION 1 mg/1 ml | 🇿🇦South Africa | Pharma-Q Holdings (Pty) Ltd | active | Jan 1900 |
| ATROPINE SULPHATE OPHTHALMIC
LIQUIDS | 🇺🇬Uganda | SWISS PARENTERALS LTD | active | — |
| ATROPINE SULPHATE OPHTHALMIC
LIQUIDS | 🇺🇬Uganda | SWISS PARENTERALS LTD | active | — |
ATROPINE SULPHATE in Africa — Regulatory Overview
ATROPINE SULPHATE is registered across 5 African markets with 24 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Malawi, Zimbabwe, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 24 registrations, 15 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.